Nyxoah SA Sustainability Reports
Nyxoah SA is a medical technology company focused on the development and commercialization of innovative neurostimulation solutions to treat Obstructive Sleep Apnea (OSA). Its primary product platform is the Genio system, a patient-centered, bilateral hypoglossal nerve stimulation therapy.
Sector: Manufacturing
Country: Belgium
Exchange: Euronext Brussels
ISIN: BE0974358906
5 reports from 2020 to 2025